TEACHABLE MEDICAL NEWS

CREATED BY ELEASYS LLC

Category: cardiovascular system Page 2 of 3

Why are we trying to transplant pig hearts into human beings?

By

On October 21, 2022

In cardiovascular system, cellular basis of life, lymphatic and immune system

TeachableMedicalNews article 10222022

Teachable moment in classrooms:

  1. chemical basis of life chapter – genetic engineering can remove genes from, or add genes to DNA molecules (the chromosomes)
  2. cellular basis of life chapter – removing a gene removes a protein, while adding a gene adds proteins to the functional toolkit of cells
  3. hear chapter – blood pumping action of left ventricle delivers oxygen, nutrients to all organs
  4. immune system chapter – role of HLA proteins in the recognition of self and non-self antigens

The news item:  Recently the following news article was published:

Two pig heart transplants succeed in brain-dead recipients

Surgeons at New York University (NYU) have successfully transplanted genetically-engineered pig hearts into two brain-dead people, researchers said on Tuesday, moving a step closer to a long-term goal of using pig parts to address the shortage of human organs for transplant.

The article states that experimental transplantation of pig hearts into brain dead humans was carried out, and the hearts remained functional for the three days of the study.  The article also states that the transplanted hearts came from genetically engineered pigs in which 4 genetic alterations were done to prevent rejection, and 6 genetic modifications were done to prevent incompatibilities between pigs and humans.

So, Why Do I Care??  There are about 600,000 people in the US whose heart is about to give out (end stage heart disease), but there are only about 3800 heart transplant operations. Several people die each day because suitable donor hearts are not available for transplantation. If we could routinely transplant pig hearts into humans that would save thousands of lives.

Plain English, Please!!!  First, let’s talk about why people need a heart transplant. End stage heart disease happens either because of the degeneration of heart muscle from coronary artery disease or from viral infection, or because of heart valve problems.  Once the pumping efficiency of the heart drops

Read More

How does drug injection into the eye save people from blindness?

By

On May 24, 2022

In cardiovascular system, nervous system, special senses

TeachableMedicalNews article 05252022

Teachable moment in classrooms:

  1. special senses chapter – location of macula lutea in the retina of the eye
  2. special senses chapter – the photoreceptors rods and cones are in the retina
  3. hemodynamics chapter – capillaries are the thinnest blood vessels
  4. hemodynamics chapter – endothelial cell location in capillaries

The news item:  Recently a report appeared about a drug that restores eyesight:

New technology helps Georgetown veteran restore his eyesight

If you’re living with blurry vision, there’s a chance a new device can help you get your eyesight back without frequent visits to the doctor. The newly FDA-approved Susvimo implant helped one Georgetown veteran preserve his vision after being diagnosed with wet age-related macular degeneration.

The article states that AMD (wet, age-related macular degeneration) is the leading cause of blindness over the age 60, that this disorder is caused by growth and scarring of blood vessels under the retina, and that the drug-delivery implant has restored vision in 90% of the treated individuals.

So, Why Do I Care??  Blindness is a condition where a significant part of the eyesight is lost, and such loss has a severe negative impact on people’s lives. In the USA alone there are about a million patients with wet age-related macular degeneration, and without treatment most of them will go blind.

Plain English, Please!!!   First, let’s talk about how the structure called macula plays a role in our vision. When we say we see something, the image of that something has to be turned into a nerve impulse so

Read More

Can a new pharmaceutical lower blood cholesterol levels to improve cardiovascular health?

By

On October 30, 2021

In cardiovascular system, cellular basis of life, chemical basis of life, digestive system

TeachableMedicalNews article 10312021

Teachable moment in classrooms:

  1. chemical basis of life chapter – cholesterol is a steroid type lipid
  2. cellular basis of life chapter – cholesterol is needed to stabilize plasma membranes of our cells
  3. digestive system chapter – liver synthesizes cholesterol
  4. cardiovascular system chapter – coronary artery disease starts with cholesterol buildup in the arteries

The news item:  Recently a report appeared about lowering our blood cholesterol level:

 

FDA approves drug that lowers cholesterol in a new way

Nexletol was approved for people genetically predisposed to have sky-high cholesterol and people who have heart disease and need to further lower their bad cholesterol.

The article stated that high LDL levels are connected with risk of heart attacks, and that this new drug blocks the cholesterol making enzyme in the liver. This new drug, Nexletol, acts differently from the statin drugs that also lower blood cholesterol.

So, Why Do I Care??  In the USA over 1 million people die yearly from heart attacks and strokes, and those deaths are at least partially caused by high blood cholesterol causing blockage inside the blood vessels. While there are life style modifications and drugs we can use to lower blood cholesterol, new pharmaceuticals may increase the success of lowering blood cholesterol.

Plain English, Please!!!   First, let’s talk about what cholesterol is and how it causes cardiovascular disease. Cholesterol is an organic molecule classified as a steroid type lipid. Cholesterol makes cell membranes sturdy, so all cells need it, and cholesterol transporting trucks, called LDL (low density

Read More

How do we teach the immune system of a cancer patient to attack cancer?

By

On July 30, 2021

In cardiovascular system, cellular basis of life, lymphatic and immune system, tissues

TeachableMedicalNews article 07302021

Teachable moment in classrooms:

  1. cellular basis of life chapter– artificial DNA can direct the cell to make a new type of protein
  2. cellular basis of life chapter – receptor proteins are located in the plasma membrane
  3. tissue chapter –the liquid connective tissue nature of blood allows the separation of blood cell types
  4. immune system chapter – role of T cell in immune defense

The news item:  Recently a news report was published about a cancer patient’s fight for her life:

New treatment option for patients battling aggressive form of blood cancer

People battling relapsed or refractory (R/R) Diffuse Large B-cell Lymphoma, an aggressive blood cancer, experience a challenging treatment journey. But a recently approved CAR T cell therapy gives patients a new option.

 

The article stated that the patient had B cell lymphoma that didn’t respond to chemotherapy, and that she started a new treatment where her T cells were removed from her blood, reprogrammed to attack her cancer, and then returned into her body.  The treatment was described as the CAR T treatment where CAR stood for chimeric antigen receptor.

So, Why Do I Care??   Some leukemia type cancers and lymphoma type cancers do not respond to regular chemotherapy. While the total number of the patients is relatively low (a few thousand), the  new approach (CAR T) to cancer treatment now presents a new option for those patients with cancers resisting regular chemotherapy. Knowing how this type of treatment is created allows us to understand treatment regimens such as Kymriah, Yescarta, and Tecartus. In addition, the CAR T treatment type may inspire more out of the box thinking to defeat cancer.

Plain English, Please!!! First, let’s talk about why would we want to train our immune system. In our body only the cells of the immune system are the only ones that can find and destroy specific targets

Read More

Can we teach our immune system to attack cancer by reprogramming white blood cells?

By

On June 29, 2021

In cardiovascular system, cellular basis of life, lymphatic and immune system

TeachableMedicalNews article 06282021

Teachable moment in classrooms:

  1. cellular basis of life chapter – some proteins are located in the plasma membrane
  2. blood chapter – hematopoiesis (blood cell formation) in red bone marrow
  3. immune system chapter – role of T-cells in immune defense

The news item:  Recently an article reported on the struggles of a patient suffering with acute lymphoblastic leukemia:

 

Richmond woman benefits from game-changing cancer treatment now offered at VCU

If you knew what Rachel Elliot has been through you might call it a miracle that she is alive and well today, but hers was a miracle over a decade in the making.

The article described a new treatment called Kymriah, a Car-T type treatment, and stated that it involves genetic engineering T-cells.

So, Why Do I Care??  Some cancers resist traditional chemotherapy treatments. Patients suffering from those cancers have very limited life expectancy.  While the total number of ALL cases, close to 6,000 each year, are relatively few, children under the age of 5 are affected mostly.  New cancer treatment approaches that think outside the box are the treatments that bring hope, and eventually cures to those patients.

Plain English, Please!!!

First, let’s talk about what acute lymphoblastic leukemia (ALL) is. This type of leukemia is the cancer of the red bone marrow, and the uncontrolled division of some cells in the bone marrow leads to a large

Read More

How can a catheter device seal an unwanted open blood vessel near the heart of prematurely born babies?

By

On February 26, 2021

In cardiovascular system, respiratory system

TeachableMedicalNews article 02262021

Teachable moment in classrooms:

  1. heart chapter – aorta and pulmonary trunk around the heart
  2. blood vessel anatomy chapter – blood vessels at the start of the pulmonary and systemic circulations
  3. blood vessel anatomy chapter – modified blood circulations in the fetus
  4. respiratory system chapter – blood vessel carrying blood to and from lungs

The news item:  the following report was published recently,

FDA approves new closure device for heart defect in premature babies

One out of 10 of all babies are born premature.

 

The article states that every year about 12,000 very low birthweight premature babies develop a disorder called patent ductus arteriosus (PDA), and that the Amplatzer Piccolo Occluder device seals an opening between two blood vessels.

So, Why Do I Care??  As the article stated 12,000 prematurely born low birthweight babies can be helped by this device. Imagine a tiny newborn whose lungs are not working properly, because not enough blood flows to the lungs. Such respiratory distress is life threatening, so a new device can give those newborns a much better chance for survival.

Plain English, Please!!!

First, let’s talk about what the ductus arteriosus is.  The ductus arteriosus is a quarter-inch long blood vessel that connects the aorta and the pulmonary trunk near the heart. Imagine that the pulmonary

Read More

How could a new non-pacing electronic device help chronic heart failure patients?

By

On November 25, 2020

In cardiovascular system, cellular basis of life, muscular system

TeachableMedicalNews article 11252020

Teachable moment in classrooms:

  1. cellular basis of life chapter – protein synthesis in cells can be changed by stimulus
  2. muscle tissue chapter – thick and thin filaments in the sliding filament muscle contraction model
  3. muscle tissue chapter – the role of calcium in muscle contraction model
  4. heart chapter – relationship of stroke volume to cardiac output

The news item:  Recently a new electronic device, Optimizer Smart, was in the news:

https://www.cnbc.com/2019/03/25/fda-approves-new-device-for-patients-with-chronic-heart-failure.html

The article states that this device is not a pacemaker; it sends non-excitatory signals, and this way it improves the squeezing ability of the heart which, in turn, improves the physical abilities of the heart failure patients.

So, Why Do I Care??  In the USA there are about 5 million people living with congestive heart failure. There are over 500,000 new cases every year, and 280,000 deaths. The people who live with congestive heart failure have a diminished quality of life because their physical activities are limited. Any new approach to help those patients is welcome news.

Plain English, Please!!!  First, let’s talk about what heart failure is. Contrary to popular belief “heart failure” doesn’t mean that the heart stops beating. Heart failure means that the cardiac output (the blood volume pumped out each minute)

Read More

Can a self-injected treatment help asthma sufferers?

By

On July 26, 2020

In cardiovascular system, cellular basis of life, chemical basis of life, respiratory system, tissues

TeachableMedicalNews article 07262020

Teachable moment in classrooms:

  1. chemical basis of life chapter – protein structure determines biological activity
  2. cellular basis of life chapter – concept of receptor proteins in cell membranes
  3. tissue chapter – locations of smooth muscle
  4. immune system chapter – cytokines as stimulators of immune functions
  5. cardiovascular system chapter – white blood cell types in circulating blood
  6. respiratory system chapter – dilation and constriction of bronchioles

The news item:  Recently a new form of asthma treatment was in the news:

‘Life-changing’ asthma injection will be offered to patients

Around 100,000 patients in the UK whose symptoms are too bad for traditional inhalers or steroids will be eligible for treatment with benralizumab.

The article mentions the disorder eosinophilic asthma, that it is caused by too many white blood cells in the lungs, and that this asthma limits what sufferers may do in their day to day lives.

So, Why Do I Care??  Asthma is a respiratory disorder that afflicts 2.5 million people in the USA. In the age group of 35-50 year olds the eosinophilic asthma is the most frequent. Inhaled pharmaceuticals, common for asthma treatment, come with undesirable side effects after long-term use.  Attacking asthma from a different angle provide a new way to treat patients, and it may help people where inhaled asthma treatments fail.

Plain English, Please!!! First, let’s talk about asthma. While asthma may be started by different conditions, like allergies, cold temperature, the root cause of asthma is always the unwanted restriction of airflow into the lungs.  An important part of our respiratory system is made up of tubes that channel air deep into our lungs, to the air sacks. A set of those tubes, the bronchioles, are 1/20 of an inch in diameter, and they have the ability to narrow and restrict airflow, because the bronchioles have smooth muscle in their walls. When those smooth muscles contract, the narrowed bronchiole restricts airflow to the air sacks.

Read More

How could the antiproliferative drug Jakafi help us defeat the SARS-CoV-2 coronavirus?

By

On May 7, 2020

In cardiovascular system, lymphatic and immune system, respiratory system

TeachableMedicalNews article 05072020

Teachable moment in classrooms:

  1. blood chapter – white blood cell types and their functions
  2. blood chapter – hematopoiesis in red bone marrow
  3. respiratory system chapter – alveoli as the sites of gas exchange
  4. respiratory system chapter – immune defense cells of alveoli
  5. lymphatic and immune system chapter – events of inflammation

How could the anti-proliferative drug Jakafi help us defeat the SARS-CoV-2 coronavirus?

The news item:  Recent articles reported that the anti-proliferative drug will be evaluated as potential treatment of SARS-CoV-2 infected patients:

Incyte drug could be part of COVID-19 treatment

A global biopharmaceutical company based in Delaware is working to get one of its drugs approved to treat the new coronavirus disease. Officials at Incyte…

The news item mentions that the drug may inhibit cytokine storm in coronavirus infected patients.

Read More

How could the drug Opaganib help us defeat the SARS-CoV-2 coronavirus?

By

On May 2, 2020

In cardiovascular system, cellular basis of life, lymphatic and immune system, respiratory system

TeachableMedicalNews article 05022020

Teachable moment in classrooms:

  1. cellular basis of life chapter – cell cycle and mitosis
  2. blood chapter – white blood cell types and their functions
  3. respiratory system chapter – alveoli as the sites of gas exchange
  4. respiratory system chapter – immune defense cells of alveoli
  5. lymphatic and immune system chapter – events of inflammation

How could the drug Opaganib help us defeat the SARS-CoV-2 coronavirus?

The news item:  Recent articles reported that the investigational drug Opaganib will be evaluated as potential treatment of SARS-CoV-2 infected patients:

https://www.timesofisrael.com/2-israeli-covid-19-patients-improve-in-experimental-drug-trial/

The news item mentions that the drug has an anti-inflammatory effect, and that it is a sphingosine kinase inhibitor.

Read More

Page 2 of 3

Previous

Next

Powered by WordPress & Theme by Anders Norén